| Author (Year) |
Total number vaccinated |
N (%) chronic kidney disease |
N (%) Diabetes |
N (%) Chronic lung disease |
N (%) cardiovascular disease |
N (%) Immunodeficiency disorder |
N (%) Neuromuscular/Neurological disorder |
| Corchado-Garcia et al. (2021) [8] |
8,889 |
- |
- |
- |
- |
- |
- |
| Naleway et al. (2021) [9] |
344,848 |
32 (0.009) |
24 (0.007) |
24 (0.007) |
- |
- |
- |
| Johnson et al. (2022) [10] |
2,866,517 |
- |
- |
- |
- |
- |
10 (0.0003) |
| Danza et al. (2022) [11] |
281,038 |
- |
- |
- |
- |
- |
- |
| White et al. (2021) [12] |
18,242 |
- |
- |
- |
- |
- |
- |
| Dunkle et al. (2022) [13] |
17,312 |
- |
- |
- |
- |
- |
- |
| Olson et al. (2022) [14] |
345 |
- |
28 (8.1) |
81 (23.5) |
27 (7.8) |
- |
- |
| Polinski et al. (2022) [15] |
422,034 |
21,904 (5.2) |
69,272 (16.5) |
50,486 (12) |
191,134 (45.3) |
1,563 (0.4) |
121,537 (28.8) |
| Griffin et al. (2021) [16] |
12,326 |
- |
- |
- |
- |
- |
- |
| Tenforde et al. (2021) [17] |
307 |
- |
140 (45.6) |
91 (29.6) |
252 (82) |
123 (40) |
- |
| Taylor et al. (2021) [18] |
782 |
- |
- |
- |
- |
- |
- |
| Chung et al. (2021) [19] |
21,272 |
- |
- |
- |
- |
- |
- |
| Tenforde et al. (2022) [20] |
314 |
- |
112 (35.7) |
100 (31.8) |
236 (75.2) |
128 (40.8) |
- |
| Xu et al. (2022) [21] |
6,398,361 |
- |
- |
- |
- |
- |
- |
